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1. Introduction
  Toxoplasma gondii (T. Gondii) is an obligate intracellular 
parasite. It causes a variety of clinical syndromes that are 
usually asymptomatic in most immuncompetent individuals, 
but the infection is more severe in immuncompromised 
individuals and in cases of congenital toxoplasmosis[1]. 
Host protection to T. gondii infection results from a 
complex cell mediated immune response involving 
inflammatory cells, lymphocytes and macrophages, and 
cytokines[2]. Activated macrophages by interferon (IFN)-
毭 inhibit parasite replication through a number of 
potent microbicidal mechanisms, such as oxidative and 
non-oxidative mechanisms as well as the induction by 
IFN-毭 of indoleamine 2,3-dioxygenase that degrades 
tryptophan, which is required for T. gondii replication. 
These mechanisms highlight the important role of IFN-毭 to 
control the infection in immunocompetent hosts[3]. 
  Briefly, the outcome of an infection with this parasite 
depends on a balance between pro-inflammatory 
[interleukin (IL)-12, IFN-毭, tumor necrosis factor (TNF)-毩] 
and anti-inflammatory (IL-10, lipoxin A4, IL-27) signals that 
suppress parasite proliferation and control the inflammatory 
response, respectively. Considering the lifelong presence 
of the parasite, hosts infected with T. gondii must develop 
a powerful immune response that has to be under strict 
control and such control should persistently be maintained 
in all infected tissues[4,5]. When endogenous IL-10 or 
transforming growth factor (TGF)-1毬 was blocked in cell 
culture, it was observed that the parasite infection was 
under control only in the presence of  IFN-毭[6].
  Cell-mediated immune mechanisms play a major role 
in the control of T. gondii infection because the parasite 
is exclusively localized intracellularly. IFN-毭 is the 
main cytokine involved with acute as well as with chronic 
resistance to T. gondii infection and recent studies have 
shown that the production and the response to IFN-毭 must 
occur on both hematopoietic and nonhematopoietic cell 
lines in order to acquire an optimal protective host effect[7]. 
It has been demonstrated that these pro-inflammatory 
cytokines, especially IFN-毭, play a major role in the 
protection of the infected host, since they control tachyzoite 
growth[8].
  Studies in the mouse model have provided important 
insights into how cellular immunity functions to control T. 
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gondii[8-11]. Infection with the highly virulent RH strain led 
to widespread parasite dissemination and rapid death of 
mice[9]. In this study, we aimed to determine the changes in 
the cytokine profiles acute toxoplasma infection in a mouse 
model of toxoplasmosis and thus, we could understand the 
immunological mechanisms formed  in toxoplasma infection. 
Since a favourable outcome of toxoplasma infection depends 
on the balance between pro-and anti-inflammatory 
responses, we investigated the mouse serum levels of IL-12, 
IL-10, IL4, TNF-毩, IFN-毭 and TGF-1毬. 
2. Materials and methods
2.1. Animal model
  Male mice (n=8) Mus domesticus domesticus at the age 
of  6-8 weeks and weighing between 18-21 g were selected 
for this study. These animals were maintained at Gazi 
University under conventional conditions. All experimental 
procedures on mice were consistent with International 
Guiding Principle for Biomedical Research Involving 
Animals and our research plan was approved by Local 
Ethics Committee for Experiments on Animals at Gazi 
University (No: 2006/06.025). The animals in infected group 
were inoculated with highly virulent T. gondii RH strain 
at a dose of 50.0 tachyzoites in 0.1 mL intraperitoneally. 
Eight animals were assigned in the healty control group 
including same features. From each study group one mouse 
was sacrificed at 72th hours following the inoculation 
consecutively.  
2.2. Cytokine levels
  For cytokines assay, cardiac blood sample was collected. 
After centrifugation, the plasma was seperated and stored at 
-80 曟 until they were analyzed. Levels of cytokines (TNF-
毩, IFN-毭, IL-12, IL-4, IL-6, TGF-1毬) were determined 
by specific enzyme-linked immunosorbent assay (ELISA) 
techniques according to the manufacturer’s instructions 
(Biosource, California, USA). The concentration of cytokines 
was determined spectrophotometrically. The absorbance 
was read at 450 nm. We constructed a standard curve 
using cytokine standards. The cytokine concentrations for 
unknown samples were calculated according to the standard 
curve.
2.3. Statistical analysis 
  In control group and infected mouse group, cytokine 
levels were analysed using SPSS (13.0 version) with the 
Mann Whitney U test, and at P<0.05 was considered to be 
significant.
3. Results
  In this study we observed that the concentrations of TNF-毩, 
IFN- 毭, IL-10 and IL-12 in infected mice were significantly 
higher than those in uninfected controls (P<0.05). The 
levels of TGF-1毬 decreased in mice infected with T. 
gondii, compared to those of the controls, the decrease was 
statistically significant (P<0.05) (Figure 1). There was no 
significant difference in levels of IL-4 between infected and 
healty control groups (P>0.05) (The data was not shown).  
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Figure 1. The cytokine levels of in infected and control groups.
4. Discussion
  We found out that acute infection of mouse with T. gondii 
leads to the Th1 response, characterized by the production 
of cytokines such as TNF-毩, IL-2, IL-12. While in mice 
infected with T. gondii the levels of IL-4, an indicator of Th2 
response, did not differ significantly from those of controls, 
IL-10 levels were observed to increase significantly during 
T. gondii infection. In our study, regulatory cytokine TGF-1b 
decreased in the infected group. Therefore, it was observed 
that the Th1 response was determined to be more dominant 
during acute T. gondii infection.
  The immune response to T. gondii infection is complex, 
compartmentalized and it varies from individual to 
individual. This individual variation can be explained by 
the high level of heterogenity in genetic background[1]. 
Considering the complexity of the immunological events 
triggered during toxoplasmosis, the relevance of segregation 
of the immune response into types 1 and 2 still warrants 
further study. Cytokines have been shown to play an 
important role in the pathogenesis of toxoplasmosis. The 
induction of a type 1 inflammatory cytokine (IL-12, TNF-
毩 and IFN-毭) response is a key event in the initiation of 
immunity to T. gondii[12]. Moreover, this pro-inflammatory 
context may lead to a modulation of immune responses, 
either directed against parasite or unrelated antigens that 
develop in the host concomitantly with the infection. IFN-毭
, the main cytokine responsible for immunological defense 
against T. gondii, is essential in all infected tissues. Since 
IFN-毭 has been shown to be a potent inhibitor of Th2 cell 
proliferation, T. gondii infection may be expected to result 
in a preferential differentiation of T helper cells towards the 
Th1 type[13].
  The overproduction of type 1 cytokines, in particular 
IFN-毭, may lead to immune hyperactivity in susceptible 
hosts  as observed in our model using Mus domesticus in 
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acute toxoplasmosis[14]. An exacerbated and persistent 
inflammatory immune reaction mediated by IFN-毭 
stimuli would lead to a noxious cellular effect on host 
tissue, especially in the cerebral nervous system[15]. Gene 
knock-out mice have established the importance of type 1 
cytokines, such as IFN-毭, IL-12 and TNF-毩, in the control 
of experimental toxoplasmosis. Absence of any one of these 
pro-inflammatory mediators results in increased mortality 
during infection as a result of uncontrolled tachyzoite 
growth[8].
  Nguyen et al detected that virulent strain RH induced 
in BALB/c mice is a type 1 cytokine pattern with T-cell-
independent overproduction of IL-12 and IFN-毭. High 
levels of circulating IL-12 and IFN-毭 were detected in the 
serum of mice infected with strain RH, although TNF-毩 
levels remained low. Administration of antibody against 
IL-12 or IFN-毭 significantly delayed time to death of 
mice infected with strain RH compared to controls[10]. We 
observed that type 1 response was prominent in this study. 
High levels of circulating IL-12 and IFN-毭 were detected 
in BALB/c mice infected with strain RH. At the same time, 
circulating TNF-毩 was remarkably increased increased 
in the sera of infected groups[10,16]. Administration of anti-
IL-12 or anti-IFN-毭 antibodies in IL10-deficient mice 
resulted in delayed time for death. Moreover, SCID mice die 
from infection with low virulent strain ME49, which triggers 
prolonged overproduction of IL-12 and IFN-毭[17]. Mordue et 
al reported similar findings of acute toxoplasmosis leading 
to lethal overproduction of Th1 cytokines, including IL-12, 
IL-18 and IFN-毭, by using the high virulent strain RH[14].
IL-10, which is produced by a variety of cell types (i.e., 
Th2 lymphocytes, macrophages, B cells, and mast cells), is 
now known to have multiple biologic activities, its major 
function appears to be inhibition of monokine (IL-l毬, TNF-
毩, and IL-12) synthesis by macrophages as well as down-
regulation of IFN-毭 production by CD4+ Thl lymphocytes 
and NK cells. Paradoxically, infections with different 
intracellular pathogens, including T. gondii, induce both 
IL-10 and IFN-毭 simultaneously[2,3]. In our study, both IL-
12 and IL-10 serum levels of infected mice were detected 
higher than healthy control group. IL-10 plays an important 
role in the balance between protective immunity and the 
development of immune pathology. IL-10 has been shown to 
act in the down-regulation of IFN-毭 production in C57BL/6 
mice following perioral infection with T. gondii, strain ME-
49[18]. It is well known that IL-10 also inhibits the production 
of IL-12, TNF-毩 and IL-6 and that T. gondii infection is 
dominated by a strong type 1 response, characterized by 
high systemic levels of IL-12 and IFN-毭[19]. To examine the 
function of IL-10 synthesis during early infection with the 
intracellular protozoan T. gondii, IL-10 knockout mice were 
inoculated with an avirulent parasite strain (ME-49) levels of 
IL-12 and IFN-毭 in sera of infected IL-10 deficient animals 
were four to sixfold higher than those in sera from control 
mice. Early IL-10 production may serve an additional and 
perhaps more important function; protection of the host 
against the detrimental effects of an excessive cellular 
immune response elicited during acute infection[8,20]. In 
toxoplasmosis, the in vivo administration of an anti-IL-10 
monoclonal antibody to SCID mice delays the death of the 
animals following Toxoplasma infection[21]. In vivo studies 
have also shown that resistance to acute toxoplasmosis can 
be abrogated by treatment with neutralizing Abs against 
IFN-毭, TNF-毩 or IL-12[20]. Aldebert et al demonstrated that 
infection by live parasites (RH strain) triggers secretion of 
IL-12, but low level of IL-10 in human monocyte cell line[22]. 
Early stimulation of macrophages also plays an important 
role in directing cell mediated immunity since IL-12 
promotes Th1-type acquired immunity, which is essential 
to control Toxoplasma infection. The balance between 
IL-12 and IL-10 is thus essential to control Toxoplasma 
infection[23].
  IL-4 is secreted by type-2 lymphocyte. IL-4 alone does not 
appear to influence the intracellular growth of Toxoplasma 
in vitro[24]. Nevertheless, in mice models, endogenous 
IL-4 plays a significant role in resistance to T. gondii[25]. 
However, Calabrase et al did not detect any significant 
levels of IL-4 in serum between  infected mice with low 
virulent strain ME-49 and uninfected control group[11]. 
According to our findings, there was no difference about 
IL-4 serum levels between infected and non-infected mice 
group. 
  TGF-1毬 is anti-inflammatory cytokine and produced 
by virtually all types of cells and plays an important role 
in immunoregulatory processes. TGF-1毬 is considered to 
be an antagonist of TNF-毩, IFN-毭, TNF-1毬  and IL-2. 
The anti-inflammatory action of this cytokine makes it 
possible to control the development of immunopathological 
phenomena related to a type 1 immune response in the 
intestines or the brain[2]. The inhibitory effect of TGF- 1
毬 on toxoplasmastatic activity is mediated via inhibition 
of TNF-毩 demonstrated an essential role of TNF-毩 in the 
IFN-毭-induced generation of these activities of murine 
macrophages. For the induction of these activities, the IFN-
毭 induced production of TNF-毩 during the initial phase 
of macrophage activation, prior to T. gondii infection, is 
essential[26]. In this study, we determined lower level of 
TGF-1毬 in serum of infected mice  than control group.
  Our findings suggest that depending on host factors, 
virulence of T. gondii strains, duration of infection, the 
cytokine profiles changed, protective or regulatory cytokine 
response were dominant. Further characterization and 
purification of Toxoplasma molecule(s) implicated in the 
regulation of cytokines could lead to the development of new 
drug prospects to control Toxoplasma infection.
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